Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krag

Showing results (1001-1010 of 1,158) with videos related to

Pageof 116
Sort By:
BMC Psychiatry|August 30, 2023
Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trialBolette Skjødt Rafn, Martin Færch Andersen, Victor Sørensen, et al.
Disease Models & Mechanisms|December 19, 2019
Absence of p.R50X <i>Pygm</i> read-through in McArdle disease cellular modelsGuillermo Tarrasó, Alberto Real-Martinez, Marta Parés, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2024
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort studyMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
BMJ Open|November 30, 2022
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trialVivian Kliim-Hansen, Lærke Smidt Gasbjerg, Anne-Marie Ellegaard, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2024
Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseStine Johansen, Simon Langkjær, Ditlev Nytoft Rasmussen, et al.
Neuromuscular Disorders : NMD|August 20, 2020
Results of an open label feasibility study of sodium valproate in people with McArdle diseaseRenata S Scalco, Mads Stemmerik, Nicoline Løkken, et al.
Frontiers in Immunology|February 9, 2023
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responsesDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Pageof 116

Showing results (1001-1010 of 1,158) with videos related to

Sort By:
Pageof 116
BMC Psychiatry|August 30, 2023
Value of gym-based group exercise versus usual care for young adults receiving antipsychotic medication: study protocol for the multicenter randomized controlled Vega trialBolette Skjødt Rafn, Martin Færch Andersen, Victor Sørensen, et al.
Disease Models & Mechanisms|December 19, 2019
Absence of p.R50X <i>Pygm</i> read-through in McArdle disease cellular modelsGuillermo Tarrasó, Alberto Real-Martinez, Marta Parés, et al.
The Lancet. Gastroenterology & Hepatology|January 13, 2024
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort studyMads Israelsen, Nikolaj Torp, Stine Johansen, et al.
BMJ Open|November 30, 2022
Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trialVivian Kliim-Hansen, Lærke Smidt Gasbjerg, Anne-Marie Ellegaard, et al.
Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.
Journal of Hepatology|March 1, 2024
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver diseaseKatrine Holtz Thorhauge, Georg Semmler, Stine Johansen, et al.
JHEP Reports : Innovation in Hepatology|March 15, 2024
Infections increase the risk of decompensation and death in patients with early alcohol-related liver diseaseStine Johansen, Simon Langkjær, Ditlev Nytoft Rasmussen, et al.
Neuromuscular Disorders : NMD|August 20, 2020
Results of an open label feasibility study of sodium valproate in people with McArdle diseaseRenata S Scalco, Mads Stemmerik, Nicoline Løkken, et al.
Frontiers in Immunology|February 9, 2023
SARS-CoV-2 spike HexaPro formulated in aluminium hydroxide and administered in an accelerated vaccination schedule partially protects Syrian Hamsters against viral challenge despite low neutralizing antibody responsesDennis Christensen, Charlotta Polacek, Daniel J Sheward, et al.
The Lancet. Gastroenterology & Hepatology|July 10, 2018
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysisEric Nguyen-Khac, Maja Thiele, Cosmin Voican, et al.
Pageof 116